The Valencian Institute of Oncology (IVO) is a private, non-profit Cancer Center devoted to prevention, diagnosis, treatment, research and training in cancer.
Since its foundation in 1976, the IVO has been a benchmark in the treatment of oncological processes, offering, as a monographic cancer center, comprehensive care for cancer patients and their families from a multidisciplinary perspective.
In 2023, the IVO took care of more than 7,000 new patients and more than 24,000 prevalent patients. The cancer center counts on cutting-edge technologies, clinical trials with early-phase unit, radiotherapy, radiology, robotic surgery and early diagnosis programes in breast cancer, gynecological malignancies, lung and prostate cancer.
The IVO has been accredited as a Clinical Cancer Center by the Organization of European Cancer Institutes (OECI) since 2015 and, in addition, it has many other certifications and accreditations that highlight its commitment to cancer patient care (ISO9001; ISO15189; ISO14001 ;QOPI;QH). Remarckably, IVO’s Biobank was the first European ISO20387-accredited biobank and as of today, remains as the only biobank accredited by this entity.
The structure includes 117 beds, 9 surgical suits, 51 infusion boxes at the Day Hospital Unit, ICU for adult patients among other resources. It is an accredited hospital by the Ministers of Health and Education of Spain for the residency training program (MIR) in medical oncology, radiation oncology, dermatology and radiophysics.
The Medical Oncology Department, the Paliative Care Unit and the Home Hospitalization Unit (HHU) work together to anticipate the needs of cancer patients in a comprehensive manner.
